From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease

Area of Science:

• Cardiovascular Medicine
• Pharmacology

Background:

• Atherosclerosis is a complex cardiovascular disease with multiple contributing molecular mechanisms.
• These include endothelial dysfunction, inflammation, mitochondrial dysfunction, oxidative stress, and lipid metabolism disorders.
• The complexity of atherosclerosis poses challenges for effective treatment and prevention.

Purpose of the Study:

• To review the potential therapeutic role of metformin in atherosclerosis.
• To explore metformin's mechanisms of action and targets relevant to cardiovascular disease.
• To summarize clinical trial data on metformin's efficacy in reducing cardiovascular risks.

Main Methods:

• Literature review of atherosclerosis pathogenesis.
• Analysis of metformin's known pharmacological actions.
• Synthesis of findings from clinical trials investigating metformin in cardiovascular disease.

Main Results:

• Metformin, effective in diabetes, shares pathogenic pathways with atherosclerosis.
• Clinical data suggests metformin may effectively reduce cardiovascular risks.
• Understanding metformin's targets is key to its application in cardiovascular medicine.

Conclusions:

• Metformin is a promising candidate for atherosclerosis treatment due to overlapping mechanisms with diabetes.
• Further investigation into metformin's cardiovascular benefits is warranted.
• Metformin may offer a novel therapeutic strategy for managing atherosclerosis and its complications.